How the ‘Canceling’ of DEI Impacts Cardiology
Leslie Cho and Robert Roswell explain how the rollback of diversity, equity, and inclusion initiatives will impact clinical research, patient care, and health equity.
Leslie Cho and Robert Roswell explain how the rollback of diversity, equity, and inclusion initiatives will impact clinical research, patient care, and health equity.
TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.
The findings underscore the need to treat heart failure with urgency and double down on clinician education, one expert says.
With both new and revised measures, the document’s authors aim to provide clinicians usable advice in a digestible format.
Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care.
Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care.
The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.
The main message is that absolute levels of Lp(a) matter more than which genes may have caused them, Robert Clarke says.
Bernard Prendergast and Philippe Généreux detail the EARLY TAVR trial design and outcomes.
The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).
Telling patients how many extra days they’ll be free from an event can help with shared decision-making, experts say.